Table 1.
Characteristic | Median (IQR) | Percent of sample (n=10,374 patients) |
No-show risk (n=105,628 appointments) |
||
---|---|---|---|---|---|
Odds ratio for no-show risk | |||||
Bivariate | Multivariate | ||||
Overall | 100% | 17% | |||
Age | 46 (39–52) | ||||
18–24 | 2% | 29 % | 3.04 (2.64, 3.51) | 2.55 (2.21, 2.95) | |
25–34 | 14% | 24% | 2.53 (2.29, 2.80) | 2.03 (1.84, 2.24) | |
35–44 | 26% | 19% | 1.90 (1.73, 2.07) | 1.54 (1.42, 1.68) | |
45–54 | 39% | 15% | 1.45 (1.33, 1.58) | 1.27 (1.17, 1.37) | |
55+ | 19% | 11% | 1.00 (ref) | 1.00 (ref) | |
Current gender | |||||
Male | 84 % | 17 % | 1.00 (ref) | 1.00 (ref) | |
Female | 16% | 19% | 1.20 (1.11, 1.30) | 0.88 (0.81, 0.96) | |
Race/Ethnicity | |||||
White non-Hispanic | 53 % | 15 % | 1.00 (ref) | 1.00 (ref) | |
Black non-Hispanic | 29% | 21% | 1.59 (1.49, 1.70) | 1.39 (1.31, 1.48) | |
Hispanic | 16% | 18% | 1.29 (1.18, 1.40) | 1.08 (1.00, 1.16) | |
Other | 3% | 18% | 1.29 (1.10, 1.51) | 1.14 (1.00, 1.30) | |
HI V infection risk group | |||||
MSM (no IDU) | 64 % | 15 % | 1.00 (ref) | 1.00 (ref) | |
IDU | 14% | 22% | 1.54 (1.43, 1.67) | 1.28 (1.18, 1.38) | |
Heterosexual contact | 20% | 19% | 1.31 (1.22, 1.41) | 1.28 (1.18, 1.39) | |
Other | 1% | 19% | 1.29 (1.05, 1.60) | 1.16 (0.96, 1.40) | |
Health insurance type | |||||
Private | 25 % | 14 % | 1.00 (ref) | 1.00 (ref) | |
Public | 57% | 18% | 1.38 (1.28, 1.48) | 1.11 (1.04, 1.19) | |
Uninsured | 17% | 20% | 1.59 (1.45, 1.74) | 1.23 (1.14, 1.33) | |
Time in care at CNICS site (years) | 5 (2–9) | ||||
<1 year | 16 % | 18 % | 1.22 (1.13, 1.33) | 0.96 (0.88, 1.04) | |
1–2 years | 22% | 18% | 1.23 (1.14, 1.33) | 0.88 (0.81, 0.95) | |
3–4 years | 15% | 17% | 1.16 (1.06, 1.27) | 0.93 (0.86, 1.01) | |
5–9 years | 26% | 17% | 1.16 (1.08, 1.25) | 0.95 (0.89, 1.02) | |
10+ years | 21% | 15% | 1.00 (ref) | 1.00 (ref) | |
CD4 count (cells/mm3) | 506 (320–709) | 1.02 (0.94, 1.10) | |||
<200 | 12 % | 21 % | 1.41 (1.31, 1.53) | ||
200–349 | 16% | 18% | 1.17 (1.10, 1.26) | 1.04 (0.98, 1.12) | |
350–499 | 20% | 18% | 1.14 (1.07, 1.20) | 1.05 (0.99, 1.11) | |
500+ | 51% | 16% | 1.00 (ref) | 1.00 (ref) | |
HIV RNA viral load (copies/mL) |
<75(<75-<75) | 1.00 (ref) | |||
<75 | 75 % | 15 % | 1.00 (ref) | ||
75–999 | 10% | 20% | 1.37 (1.29, 1.47) | 1.12 (1.05, 1.20) | |
1,000–9,999 | 5% | 23% | 1.69 (1.54, 1.84) | 1.24 (1.13, 1.36) | |
10,000–99,999 | 6% | 26% | 1.93 (1.78, 2.08) | 1.27 (1.16, 1.39) | |
100,000+ | 3% | 25% | 1.89 (1.70, 2.09) | 1.21 (1.07, 1.36) | |
Antiretroviral status | 1.00 (ref) | ||||
On ART, adherent | 55 % | 14 % | 1.00 (ref) | ||
On ART, non-adherent | 31% | 21% | 1.61 (1.53, 1.69) | 1.27 (1.21, 1.33) | |
Not on ART | 14% | 22% | 1.77 (1.66, 1.89) | 1.16 (1.08, 1.25) | |
Number of missed visits, past year | 1.00 (ref) | ||||
0 | 1 (0–2) | 47 % | 10 % | 1.00 (ref) | |
1 | 21% | 18% | 1.94 (1.84, 2.04) | 1.75 (1.65, 1.85) | |
2 | 11% | 23% | 2.74 (2.57, 2.92) | 2.38 (2.22, 2.55) | |
3 | 6% | 26% | 3.25 (3.00, 3.51) | 2.70 (2.47, 2.95) | |
4+ | 14% | 31% | 4.10 (3.80, 4.41) | 3.42 (3.16, 3.70) | |
Depressive symptoms | 6 (1–11) | 1.00 (ref) | |||
None (0–4) | 45 % | 15 % | 1.00 (ref) | ||
Mild (5–9) | 25% | 17% | 1.14 (1.08, 1.20) | 0.95 (0.89, 1.00) | |
Moderate (10–14) | 14% | 20% | 1.36 (1.27, 1.45) | 1.03 (0.96, 1.10) | |
Moderately severe (15–19) | 10% | 20% | 1.41 (1.30, 1.52) | 1.02 (0.94, 1.11) | |
Severe(20–27) | 7% | 21% | 1.46 (1.32, 1.61) | 0.95 (0.85, 1.05) | |
Anxiety symptoms | 0 (0–4) | 1.00 (ref) | |||
None (0) | 66% | 16% | 1.00 (ref) | ||
Some (1–4) | 16% | 18% | 1.16 (1.09, 1.24) | 1.05 (0.98, 1.12) | |
Likely panic disorder (5) | 18% | 21% | 1.39 (1.31, 1.49) | 1.06 (0.98, 1.14) | |
Alcohol use | 1(0–3) | 1.00 (ref) | |||
None (0) | 39% | 16% | 1.00 (ref) | ||
Non-hazardous (1–2/1–3)* | 38% | 17% | 1.02 (0.97, 1.08) | 1.04 (0.98, 1.09) | |
Hazardous(≥3/≥4)* | 22% | 20% | 1.26 (1.18, 1.35) | 1.20 (1.13, 1.27) | |
Current illicit drug use | 1.00 (ref) | ||||
None | 84% | 15% | 1.00 (ref) | ||
Any (non-marijuana) | 16% | 26% | 1.97 (1.85, 2.09) | 1.32 (1.24, 1.41) |
Cutpoints for women and men, respectively MSM: Men who have sex with men. IDU: Injection drug use.